Is glucagon an antidote for beta (beta) blocker (beta-adrenergic blocking agent) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Glucagon can be used as an antidote for beta blocker overdose, given as 3-10 mg IV bolus, followed by an infusion of 3-5 mg/hour, to help counteract cardiovascular depression by activating adenylyl cyclase through a pathway independent of beta-receptors. In beta blocker toxicity, glucagon can help increase cardiac contractility and heart rate by bypassing the blocked beta receptors. However, glucagon should be considered as just one component of comprehensive management, which may also include:

  • IV fluids
  • Vasopressors
  • Calcium
  • High-dose insulin therapy
  • In severe cases, lipid emulsion therapy or extracorporeal support The effectiveness of glucagon can be limited in severe overdoses, and its effects may be transient. Additionally, glucagon can cause side effects including nausea, vomiting, and hyperglycemia. Treatment should be initiated promptly and managed in a hospital setting, ideally with consultation from a poison control center or toxicologist 1. Some key points to consider when using glucagon for beta blocker overdose include:
  • The recommended dose of glucagon is a bolus of 3 to 10 mg, administered slowly over 3 to 5 minutes, followed by an infusion of 3 to 5 mg/h 1
  • The infusion rate is titrated to achieve an adequate hemodynamic response (appropriate mean arterial pressure and evidence of good perfusion) 1
  • Glucagon commonly causes vomiting, and in patients with central nervous system depression, the airway must be protected before glucagon administration 1

From the FDA Drug Label

• Beta-blockers: Patients taking beta-blockers may have a transient increase in pulse and blood pressure. Table 1: Clinically Significant Drug Interactions with Glucagon for Injection Beta-Blockers Clinical Impact: Patients taking beta-blockers may have a transient increase in pulse and blood pressure when given Glucagon for Injection. Intervention: The increase in blood pressure and heart rate may require therapy in patients with coronary artery disease

Glucagon is not an antidote for beta blockers. It may even cause a transient increase in pulse and blood pressure in patients taking beta-blockers, which may require therapy in patients with coronary artery disease 2 2 2.

From the Research

Glucagon as an Antidote for Beta Blocker Overdose

  • Glucagon has been studied as a potential antidote for beta blocker overdose, with some evidence suggesting its effectiveness in reversing the cardiovascular depression associated with beta-blockade 3, 4.
  • The mechanism of action of glucagon in this context is thought to bypass the beta-adrenergic receptor site, allowing it to increase heart rate and myocardial contractility even in the presence of beta-receptor blocking drugs 3.
  • Studies have reported the use of glucagon in cases of severe beta-blocker overdose, with doses ranging from 50 micrograms/kg iv loading dose to 1-15 mg/h continuous infusion 3, 4.
  • While glucagon may be effective in improving haemodynamics, its use is not without potential side effects, including nausea, vomiting, hypokalemia, and hyperglycemia 3.

Comparison with Other Treatments

  • Other treatments for beta-blocker overdose, such as catecholamines, vasopressors, and high-dose insulin euglycaemic therapy, have also been studied and may be effective in improving haemodynamics and reducing mortality 5, 6.
  • The choice of treatment may depend on the specific circumstances of the overdose and the patient's response to initial therapy.
  • Glucagon may be considered as an alternative therapy for profound beta-blocker intoxications, particularly in cases where other treatments are not effective or available 3, 4.

Limitations of the Evidence

  • The evidence supporting the use of glucagon in beta-blocker overdose is largely based on case reports and animal studies, with limited human data available 5, 7.
  • Further research is needed to fully establish the efficacy and safety of glucagon as an antidote for beta-blocker overdose.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Glucagon therapy for beta-blocker overdose.

Drug intelligence & clinical pharmacy, 1984

Research

Beta-blocker toxicity--the role of glucagon. Report of 2 cases.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1985

Research

Treatment for beta-blocker poisoning: a systematic review.

Clinical toxicology (Philadelphia, Pa.), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.